Unravelling the mechanisms underlying cardiomyocyte death in right ventricular remodelling during pulmonary arterial hypertension:Deciphering the pathway towards cardiac remodelling
Cell death is a vital process that plays a crucial role in the human body,particularly in cardiac pathology.Various forms of cell death,including apoptosis,necroptosis,mitochondrial permeability transition-induced necrosis,pyroptosis,ferroptosis,and autophagy,are intricately involved in cardiac remodeling and heart failure associated with different cardiovascular diseases.Pulmonary arterial hypertension exerts substantial pressure on the right ventricle,leading to compensatory hypertrophy as an initial response.However,this compensatory mechanism becomes unsustainable in the long run,resulting in ventricular failure accompanied by myocardial cell death.Therefore,understanding the specific mechanisms of myocardial cell death during disease progression is essential for improving patient prognosis and developing effective treatment strategies.To gain insight into myocardial cell death,it is crucial to explore the signaling pathways involved in different forms.Apoptosis,known as programmed cell death,eliminates unwanted or damaged cells and maintains tissue homeostasis.Necroptosis,a regulated form of necrosis,occurs in response to specific triggers and contributes to pathological conditions like ischemic injury.Mitochondrial permeability transition-induced necrosis disrupts mitochondrial membrane integrity,leading to cell death.Pyroptosis,characterized by the release of proinflammatory cytokines,has been implicated in cardiovascular diseases such as atherosclerosis.Ferroptosis,a recently discovered regulated cell death pathway,involves iron-dependent lipid peroxidation and has been linked to cardiac dysfunction.Autophagy,a process that maintains cellular homeostasis through cytoplasmic component degradation,can also contribute to myocardial cell death under certain conditions.Detecting and evaluating different forms of myocardial cell death are critical for disease diagnosis,prognosis,and treatment.Histological techniques,flow cytometry,immunohistochemistry,and molecular assays are among the methods used to assess cell death processes.These techniques enable researchers and clinicians to identify specific markers and evaluate the extent of cell death within cardiac tissues,leading to a comprehensive understanding of myocardial cell death for better disease management and therapeutic interventions.Extensive research has revealed the intricate interplay between cell death and disease progression in pulmonary arterial hypertension.Dysregulation of signaling pathways involved in myocardial cell death contributes to the pathogenesis of this condition and the associated right ventricular dysfunction.Understanding the molecular mechanisms underlying myocardial cell death provides valuable insights into potential therapeutic targets and strategies.By targeting specific forms of cell death or their regulatory pathways,novel treatments that mitigate disease progression,improve cardiac function,and enhance patient outcomes can be developed.Future research prospects in this field include exploring the therapeutic potential of modulating cell death pathways in pulmonary arterial hypertension.Investigating targeted therapies aimed at specific forms of cell death holds promise for developing innovative treatment options.Additionally,identifying biomarkers associated with cell death processes may enable early disease detection,monitoring disease progression,and facilitating timely intervention and personalized medicine approaches.In conclusion,this article provides an in-depth overview of the signaling pathways involved in different forms of myocardial cell death.It highlights the importance of detecting and evaluating cell death processes in cardiac pathology and summarizes current research findings in the context of pulmonary arterial hypertension.Expanding our knowledge of cell death mechanisms and their implications in cardiovascular diseases paves the way for novel therapeutic strategies and improved patient care.
NETL
NSTL
万方数据
